News & Events
- All
- Company
- Events
- Press Releases
Company
Apr 9, 2025
Published April 9, 2025 - We’re excited to share that Abselion is featured in the Spring 2025 issue of Innovations in Pharmaceutical Technology (IPT), highlighting the role of our Amperia system in...
Company
Mar 4, 2025
Abselion is delighted to announce the appointment of Kim Orton-Smith as Vice President of Sales & Marketing.
Company
Jan 2, 2025
A warm welcome to our new board members, Dr Oliver Hardick of M Ventures and Chris Major of BioProcess 360 Partners.
Press Releases
Dec 4, 2024
Series A financing highlights the potential impact of Abselion’s technology for life science research and bioprocess development
Company
Sep 17, 2024
Anne brings over 25 years of global commercial experience in the Life Sciences, Healthcare and Cell Therapy arenas.
Press Releases
Aug 20, 2024
Collaborative Project to Develop Next-Generation Cell Platform for Viral Vector Production Receives £1.1 Million Grant from Innovate UK & NRC.
Events
Dec 8, 2023
Abselion recently attended the BIA bioprocess 2023 conference and presented our Amperia platform.
Company
Aug 4, 2023
The last few years have been nothing short of amazing – together, we have achieved remarkable milestones that we can all be incredibly proud of.
